Beijing Jinchengtaier Pharmaceutical

Beijing Jinchengtaier Pharmaceutical is a specialized pharmaceutical company based in China, primarily focused on women's health and anti-infective medications. Formerly known as Beijing Langyi Pharmaceutical, the company was acquired by Jincheng Pharmaceutical Group in 2017 and subsequently rebranded to its current name. The company is a market leader in the gynecological segment, particularly known for its clindamycin phosphate vaginal gel and other treatments for vaginal infections. Beyond gynecology, Jinchengtaier produces a range of small molecule drugs for respiratory and urinary tract infections. It operates advanced manufacturing facilities in Beijing that comply with national GMP standards. As a key subsidiary of a publicly traded group, the company plays a vital role in the domestic Chinese pharmaceutical supply chain.